基于肠道微生物群研究的临床试验中季节性变化的影响
Giovanna Cocomazzi1, Concetta Panebianco1, Annamaria Vallelunga2
1Gastroenterology Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale dei Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Microorganisms
|October 29, 2025
概括
饮食和环境的季节性变化会影响人类肠道微生物群,影响健康. 未来的临床试验必须考虑这些肠道微生物变异.
科学领域:
- 微生物学 微生物学
- 人类健康 人类健康 人类健康
- 环境科学 环境科学
背景情况:
- 人体肠道微生物群的组成和功能受到季节性的显著影响.
- 季节性因素包括饮食,环境,行为和感染,在食物供应季节性时具有明显的影响.
- 肠道微生物群失生症与非传染性慢性疾病 (NCD) 有关.
研究的目的:
- 审查当前关于肠道微生物群季节性的证据.
- 讨论季节性在研究中引入的潜在偏见,特别是NCDs.
- 概述关于季节性的未来临床试验的方法考虑.
主要方法:
- 对调查肠道微生物群季节性变化的研究进行文献综述.
- 分析影响这些季节性变化的因素 (饮食,环境,行为).
- 检查季节性对肠道微生物群与免疫相互作用和疾病的影响.
主要成果:
- 肠道微生物群的组成表现出季节性变化,这可能会对健康产生影响.
- 这些变异可以影响肠道免疫系统,并导致疾病发病或恶化.
- 季节性往往被忽视为临床试验中的混变量,可能会导致结果偏见.
结论:
- 了解肠道微生物群的季节性至关重要,特别是对于非传染性疾病.
- 季节性会影响临床试验结果,影响对益生菌疗效和疾病关联的解释.
- 未来的研究和临床试验需要将季节性作为一个关键变量.
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Anatomy of the Intestines
86.7K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.7K
Factors Affecting Drug Biotransformation: Biological
513
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
513
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Bioavailability: Influencing Factors
331
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
331


